Related Experiment Video
Updated: Aug 27, 2025

10:34
Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage
Published on: August 30, 2020
10.7K
The Danish Chronic Subdural Hematoma Study-Risk Factors for Second Recurrence
Thorbjørn Søren Rønn Jensen1, Nina Andersen-Ranberg1, Frantz Rom Poulsen2
1Department of Neurosurgery, Rigshospitalet, Copenhagen, Denmark.
World Neurosurgery
|September 24, 2022
Summary
Identifying risk factors for recurrent chronic subdural hematomas (CSDH) is challenging. This study found no specific pretreatment indicators for a second CSDH recurrence, complicating personalized treatment strategies.
Area of Science:
- Neurosurgery
- Clinical Neurology
- Radiology
Background:
- Multiple recurrent chronic subdural hematomas (CSDH) present significant treatment challenges.
- Identifying specific risk factors for CSDH recurrence is crucial for personalized treatment, prognostication, and surgical strategy.
- This study aimed to identify pretreatment risk factors for a second CSDH recurrence (re-re-CSDH).
Purpose of the Study:
- To identify pretreatment risk factors for a second recurrence of chronic subdural hematoma (re-re-CSDH).
- To identify risk factors for developing re-re-CSDH after initial surgery for a first recurrence.
Main Methods:
- Retrospective analysis of clinical and demographic data from Danish neurosurgical patients (2010-2012).
- Data collected before evacuation of primary CSDH, first recurrent CSDH (re-CSDH), and re-re-CSDH.
- Comparison of patients undergoing first, second, and third CSDH evacuations to identify risk factors.
Main Results:
- The cohort included 1052 patients: 172 with re-CSDH and 29 with re-re-CSDH.
- Risk factors for re-re-CSDH included radiological subtype, midline shift, and hematoma volume.
- Postoperative drainage was associated with a lower risk of re-re-CSDH, but these factors were not specific.
Conclusions:
- Similar independent risk factors were found for re-CSDH and re-re-CSDH.
- It was not possible to identify specific pretreatment risk factors for patients at high risk of re-re-CSDH.
- Lack of specific risk factors hinders personalized treatment and prognostication for multiple CSDH recurrences.

